Using mixtures of linoleic acid, a long-chain polyunsaturated fatty acid, and its monoglyceride in lipid-based formulations to increase drug loading and enhance aqueous microemulsification
Although lipid-based formulations (LBFs) of self-emulsifying drug delivery systems (SEDDS) have been used for poorly water-soluble drugs, they have many limitations, the first being the low solubility of drugs in lipids, which limits drug loading in formulations, and the second being inadequate dispersion of formulations in the aqueous fluids of the human gastrointestinal tract (GIT). Large amounts of organic cosolvents and surfactants, up to 90% of the formulation, have been used to overcome these limitations. We previously demonstrated that the situation could be improved by using lipid digestion products (LDP), which consist of a 2:1 molar ratio of long-chain fatty acids and monoglycerides, rather than lipids (triglycerides) themselves. The drug solubility and, therefore, drug loading in the formulations increased greatly due to the presence of long-chain fatty acid in the LDP. However, only oleic acid (OA)and its monoglyceride were used in those studies. To demonstrate the versatility of the approach, mixtures of linoleic acid (LA) and glyceryl monolinoleate (GML) at a 2:1 molar ratio were used in the present study, with clofazimine (CFZ) as the model drug. Although both OA and LA are long-chain fatty acids with 18 carbon atoms, the latter has two double bonds instead of one, and it was hypothesized that an extra double bond could improve the microemulsification of the LBF, reduce particle size after emulsification in aqueous media, and enhance drug absorption in vivo. LA showed a high CFZ solubility of 480 mg/g, comparable to OA; however, it performed better in LBFs, with the developed formulation (100 mg/g) dispersing as less than 250 nm size microemulsions at intestinal pH, compared to 400 nm for OA.